Clinical trial

Trastuzumab Optimization Trial in Breast Cancer

NCT00637325

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2007-11-01

PhasePHASE3

Study timeline

Study start (unknown)2007-11-01Date precision: month

Registry last updated2008-03-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic or Locally Advanced Breast Cancerunresolved

Interventions

trastuzumabDRUG · verified · RxNorm: trastuzumab

Sponsors & collaborators

Regione Lombardialead sponsor

Mario Negri Institute for Pharmacological Researchcollaborator

Istituto Clinico Humanitascollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00637325 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.